Gandhi, Rajiv

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Riesmeyer, J. S., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 3,163

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Botros, F. T., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 638

Central nervous system involvement in diabetic neuropathy

Selvarajah, D., Wilkinson, I. D., Davies, J., Gandhi, R., & Tesfaye, S. (2011) · Current Diabetes Reports

Pain Mechanisms and TreatmentsPeripheral Neuropathies and Disorders

Cited by 102

Noninvasive evaluation of neural impairment in subjects with impaired glucose tolerance

Putz, Z., Tabák, A. G., Tóth, N., Istenes, I., Németh, N., Gandhi, R. A., Hermányi, Z., Keresztes, K., Jermendy, G., Tesfaye, S., et al. (2009) · Diabetes Care

Heart Rate Variability and Autonomic ControlDiabetes Management and Research

Cited by 90

Serum-based soluble markers differentiate psoriatic arthritis from osteoarthritis

Chandran, V., Abji, F., Perruccio, A. V., Gandhi, R., Li, S., Cook, R. J., & Gladman, D. D. (2019) · Annals of the Rheumatic Diseases

Spondyloarthritis Studies and TreatmentsOsteoarthritis Treatment and Mechanisms

Cited by 48